Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-31
2011-05-31
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S531000
Reexamination Certificate
active
07951836
ABSTRACT:
The present invention relates to compounds of formula Iwherein R1, R2, R3, X, n, and m are as defined herein and to pharmaceutically acceptable acid addition salts thereof, to pharmaceutical compositions containing them, and to methods for treating neurological and neuropsychiatric disorders.
REFERENCES:
patent: 7485637 (2009-02-01), Jolidon et al.
patent: 7605163 (2009-10-01), Jolidon et al.
patent: 2005/0154024 (2005-07-01), Bryans et al.
patent: WO 2005/014563 (2005-02-01), None
patent: WO 2005/023261 (2005-03-01), None
patent: WO 2006/077026 (2006-07-01), None
Chabrier et al. “Preparation of N-phhenyl..” CA 136:69731 (2002).
Praysse et al. “Aminopyrimidines..” CA 147:9933 (2007).
Tani et al. “Preparation of aryll . . . ” CA 138:187795 (2003).
King “Bioisosteres . . . ” Med. Chem. Principle and Practice p. 206-209 (1994).
Jolidon Synese
Narquizian Robert
Norcross Roger
Pinard Emmanuel
Chang Celia
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Substituted phenyl methanone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted phenyl methanone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted phenyl methanone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2647672